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Abstract
Background: The place of opioids in the management of chronic, non-cancer pain is limited. Even so their use is
escalating, leading to concerns that patients are prescribed strong opioids inappropriately and alternatives to
medication are under-used. We aimed to understand the processes which bring about and perpetuate long-term
prescribing of opioids for chronic, non-cancer pain.
Methods: We held semi-structured interviews with patients and focus groups with general practitioners (GPs).
Participants included 23 patients currently prescribed long-term opioids and 15 GPs from Leeds and Bradford,
United Kingdom (UK). We used a grounded approach to the analysis of transcripts.
Results: Patients are driven by the needs for pain relief, explanation, and improvement or maintenance of quality
of life. GPs’ responses are shaped by how UK general practice is organised, available therapeutic choices and their
expertise in managing chronic pain, especially when facing diagnostic uncertainty or when their own approach is
at odds with the patient’s wishes. Four features of the resulting transaction between patients and doctors influence
prescribing: lack of clarity of strategy, including the risk of any plans being subverted by urgent demands; lack of
certainty about locus of control in decision-making, especially in relation to prescribing; continuity in the doctor-patient
relationship; and mutuality and trust.
Conclusions: Problematic prescribing occurs when patients experience repeated consultations that do not meet their
needs and GPs feel unable to negotiate alternative approaches to treatment. Therapeutic short-termism is perpetuated
by inconsistent clinical encounters and the absence of mutually-agreed formulations of underlying problems and plans
of action. Apart from commissioning improved access to appropriate specialist services, general practices should also
consider how they manage problematic opioid prescribing and be prepared to set boundaries with patients.
Background
Opioids are commonly prescribed for chronic, non-
cancer pain despite limited evidence of effectiveness and
frequent adverse effects [1–4]. There are growing con-
cerns that strong opioids are prescribed inappropriately
and alternative approaches under-utilised [5–9]. Com-
munity prescribing of opioids in England has more than
doubled in the last decade, with larger increases for
more potent opioids [10, 11] reflecting international
trends [12–15]. Over a third of patients eventually more
than double their original dose of opioids and around
10 % are prescribed potentially hazardous high doses
[12]. Rather than reflecting previously untreated chronic
pain, these patterns may reflect a wider change in the
general approach to prescribing for pain [5, 16].
The therapeutic benefit of opioids in musculoskel-
etal pain is established for short but not long term
use [8, 10, 12] whilst evidence is accumulating on harms,
most commonly physical dependence, tolerance, addiction
and adverse effects [8, 17–21]. Many people with chronic
pain report difficulties with prescribed opioids, including
psychosocial problems and concerns about controlling
their medication use [22]. Non-adherence to treatment
plans is common because of side effects or fears about
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dependence [23]. Many patients report poorly controlled
pain, often resorting to self-medication and diversion as
coping strategies [22, 24–27]. Hospitalisation rates due to
opioid-related adverse events are increasing [28]. Opioid
use, even of the commonly prescribed and ‘weaker’ co-
deine, is associated with increased mortality [29].
Patients with chronic pain face challenges, such as
explaining and legitimising their symptoms [30], whilst
general practitioners (GPs) report difficulties in asses-
sing pain and concerns about prescribing strong opi-
oids [21, 31–35]. Patients and GPs often find the
management of chronic pain unsatisfactory.
We interviewed patients and GPs about their experi-
ences, beliefs and expectations of analgesia prescribing,
to improve understanding of how problematic long-term
opioid prescribing becomes established.
Methods
Design and setting
A qualitative study, comprising semi-structured inter-
views and focus groups, in general practices across Leeds
and Bradford, cities in the North of England.
Sampling
Thirty-seven (23 %) of 158 general practices approached
expressed an interest. To ensure diversity in their experi-
ences, we sampled patients from practices with high and
low opioid prescribing levels. Electronic searches identi-
fied patients aged 18 and over, with a current repeat pre-
scription for either a strong opioid (e.g. morphine) or a
weak opioid (e.g. codeine). We excluded patients with
cancer or cognitive impairment. Each practice invited up
to 60 patients by letter to contact the study team. As re-
cruitment progressed, we purposively sampled by sex,
age, recent significant changes in opioid prescriptions,
opioid strength, the presence of coded mental health
problems and ethnicity in order to maximise the range
of relevant attributes.
We invited individual GPs from the 37 practices to
take part in a focus group held in their locality, seeking
one GP from each practice.
Data collection
Semi-structured interviews (by CM and LZ) with individ-
ual patients covered accounts of their prescribing histor-
ies, experiences of treatment, and hopes and expectations
(Appendices 1 and 2).
Early patient interviews informed the development of
patient vignettes to prompt the subsequent focus group
discussions with GPs (facilitated by RF and CM). The
two vignettes illustrated patients experiencing subopti-
mal pain control on opioids. We prompted discussion
on experiences and expectations of the initiation and
maintenance of opioid prescribing, management options,
perceived ‘red flags’ for long-term opioid use and experi-
ences of trying to reduce prescribing. All interviews and
focus groups were audio taped and transcribed verbatim
following written consent.
Analysis
Constant comparison was used to analyse transcriptions.
Analysis involved deconstructing each transcript to iden-
tify primary categories (open coding). These categories
were compared with others within and across transcripts,
followed by cross-linking of categories to generate new
meanings and concepts (axial coding) then cross-linking
of concepts to generate themes (selective coding) [36]. In-
terviews and focus groups were initially coded separately.
Coding reliability was checked by two further researchers
versed in qualitative analysis (SJC and LZ).
Data collection and analysis proceeded iteratively, with
focus group findings informing later patient interviews,
allowing progressive focusing on key themes to explain
findings. The wider study team also read selected tran-
scripts before discussing emerging findings and analyses.
From the two perspectives (patient and GP) we identi-
fied, we derived an account of the main features of
transactions between patients and GPs and subsequent
prescribing decisions.
Ethical approval
The study was approved by Yorkshire and the Humber
(Humber Bridge) NRES Committee 12/YH/0109.
Results
Sixty-one out of 391 invited patients expressed an interest.
We subsequently interviewed 23 patients (17 women;
mean age 54 years; range 31 to 89 years; Table 1). Fifteen
patients were on stable, prescribed, mostly strong, opioids.
Five had stepped up opioid strength within the preceding
year and three had stepped down. The mean duration of
Table 1 Patient sample characteristics
Area of residence Bradford 12
Leeds 11
Female 17
Median age in years (range) 54 (31–89)
Mean Index of Multiple Deprivation (SD) 20 (12)
Coded mental illness 17
Current opioid strength Strong 15
Weak 5
Non-opioid 3
Trajectory (changes within the preceding year) Step-up 5
Step-down 3
Stable 15
Total 23
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opioid use was 14 years (range two to 35 years). There
were discrepancies between prescribing records and pa-
tient self-reports. For example, three patients indicated
that they were no longer taking prescribed opioids; one
because of recommendations from a specialist and two be-
cause of personal choice. All had experienced adverse side
effects coupled with minimal or no pain relief. We inter-
viewed 21 patients at their homes, one at a general prac-
tice and one at the University. Spouses were present in
two interviews. We held 12 interviews before the first GP
focus group and six were held following the second GP
focus group. Mean interview duration was 53 minutes
(range 34 to 77 minutes).
Fifteen GPs (11 female) from 13 practices (five urban
and eight rural) participated in two focus groups. One
GP had agreed to participate but subsequently did not
attend. Participants had on average 10 years’ experience
as GPs (range two to 36 years) and a median list size of
7500 patients (2400 to 25000 patients). Two GPs had
special interests in pain management, one in mental
health and one in palliative care.
Patient drivers to seek help
Patients sought pain relief, an explanation of their symp-
toms and to improve or maintain quality of life. Such
hopes and expectations often continued to be unmet
amongst those patients we interviewed. Sometimes this
was because expectations of achievable pain relief were
unrealistic:
‘[I wanted the GP] just to relieve the pain really…
more or less just give me the medication to take the
pain away. Nothing other than that.’ [Male, 61 yrs,
maintained on weak opioids, D1; 64&208]
Patients repeatedly consulted with poorly controlled
pain despite continuing or even increased doses and
strengths of pain killers. However, they often recognised
that they had to balance any benefits from pain relief
with the adverse effects of opioids. Hopes for pain relief
were tempered by fears about adverse effects of treat-
ment escalation, particularly opioid dependence:
‘… and from what I’ve read up, because I like to, sort
of, keep on top of things, that it’s an opium based drug,
so you will build up some tolerance and you will build
up [becomes tearful] And you will potentially become
sort of addicted to it, if you like.’ [Male, 47 yrs,
increasing strong opioids, C2; 62]
Patients sought an explanation for their symptoms and
often struggled to receive one. The patients we inter-
viewed often described complex narratives, sometimes
relating the onset of their symptoms to specific events
(such as accidental injuries) and often requiring multiple
investigations and consultations with primary and sec-
ondary care clinicians. They picked up partial or even
contradictory explanations for their symptoms; diagnos-
tic labels such as osteoarthritis, fibromyalgia and hyper-
mobility syndrome did not appear to sufficiently capture
their suffering. Doctors’ explanations which attributed
poorly controlled pain symptoms to lifestyle factors or
life events were received with or even fuelled scepticism:
‘Well it was like a challenge for me…because all they
did really was to tell me to lose weight, it’s the
menopause, and that was it…and I kept going to the
GP because I knew something wasn’t right. But I had
the stamina to say well I know something’s not right,
I want to be seen.’ [Female, 54 yrs, maintained on
strong opioids, G4; 38–54]
Patients’ abilities to cope with pain varied over time,
and they were driven to seek help when medication or
other coping measures no longer work and their pain in-
terferes with their usual activities. The centrality of qual-
ity of life to patients was apparent in their distress when
seeking help from GPs:
‘I don’t know how many times I’ve sat and I’ve just sat
and cried and said, I’ve had enough, you know. And
before I got on the gabapentin I just sat in the GP’s
office in floods of tears like a lumbering idiot and said
if you can’t take this pain away from my legs just chop
them off, because it’s just 24/7…’ [Female, 37 yrs,
maintained on weak opioids, G2; 105]
Features of transactions between patients and GPs
Four themes characterised not just the views of patients
or GPs, but some feature of the transactions between
them.
Absence of a shared management plan. First and
most importantly, the management of patients with
chronic pain often unfolded in the absence of a
shared long-term management plan so that prescrib-
ing occurred as a default reaction. Prescribing deci-
sions for unfamiliar patients, often with long and
complex pain histories, were made within the time
constraints of routine consultations:
‘They’ll be down for their medication review but
they’ll say, I’m here for my medication review, you’ll
spend some time doing the tablets. Oh and whilst I’m
here I’ve got this rash, I’ve got this, whatever it is. So
that automatically then reduces the time you can
actually spend looking at all of their medication
which might include their painkillers.’ [GP, female,
Leeds focus group; 246]
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Pain management was often marginalised in the con-
text of co-morbidities, especially given the absence of
clear treatment goals compared with other long-term
conditions, such as diabetes.
Patients could also receive opioid prescriptions after
telephone requests, when GPs were juggling various
other urgent calls and queries competing for their time.
GPs resorted to the compromise of prescribing further
opioids without formal medication reviews. These short-
term fixes accumulated so that repeated prescriptions or
escalating strengths of opioid became the norm for pa-
tients until either party realised that the clinical manage-
ment approach was not working. At this point, safety
concerns may have been raised or the GP may have ad-
mitted to running out of ideas on further management:
‘It seems to me that when I got to a certain level
[300mcg Fentanyl patch], it was almost like she’d [the
GP] not realised that she’d gotten me up to that....and
so now all we do is work on getting that level down.’
[Female, 37 yrs, reducing strong opioids, B3; 162, 174]
GPs were aware of the limitations of prescribed opioids,
which then compromised their abilities to formulate coher-
ent management plans. They expressed some uncertainty
about how to prescribe them appropriately and were aware
of giving conflicting advice to patients on balancing pain re-
lief against the risks of tolerance and addiction:
‘… there’s something about us not saying to patients
often enough, you know, these are addictive, take them
when you’re in pain. Because everybody always says,
you need to take them four times a day because if you
break that… your pain is going to come through. So
we’re telling them that on the one side and then on the
other side we’re saying, you’ve got to stop taking it as
soon as you’re not in any pain because otherwise
you’re going to be hooked on them and your use is
going to escalate up.’ [GP, female, Bradford; 736]
Locating control and responsibility for change. Second,
we recognised a discussion about where perceived con-
trol resided and who has the ability to make change.
Sometimes patients positioned control with their GPs:
‘And I know the doctors know what they are doing, I
suppose, but you don’t know whether to say ‘I think
these patches are working, can you up it?’ [Female,
72 yrs, maintained on strong opioids, A1;126]
At other times, patients felt responsible for controlling
the use of prescribed medication. Not infrequently, nei-
ther party felt in control and non-pharmacological ap-
proaches were limited by resource constraints:
‘He [the GP] said what exactly do you want me to do?
You've pretty much been on everything so there is
nothing for you to do. There is nothing for you to go on
to. And I was like well what exactly am I doing
coming off [strong opioids] when you've got nothing to
put me on to?' [Female, 37 yrs, reducing strong
opioids, B3; 140]
One response to this mutual lack of control was to
refer patients on for specialist assessment and manage-
ment, usually to pain clinics. Access to appropriate
pain services, especially those dealing with behavioural
and psychosocial aspects of chronic pain management,
was limited and GPs felt under pressure to do some-
thing whilst patients waited, usually increasing opioid
therapy. Referrals allowed some alleviation of clinical
responsibility but were made more in hope than in
expectation.
‘…every time I send somebody to chronic pain [clinic]
they come out with more medication, or injections.’
[GP, female; Leeds; 319]
Patients could go through several cycles of referrals
and new treatments, and of building up hopes and being
disappointed, so that each cycle reinforced a sense of
futility.
‘Well all they do really is refer me to see a specialist,
which was what they did in the first place, referred me
to see a specialist and give me tablets… It’s like you
are banging your head against the wall, you get fed up
of going there… it’s a waste of my time, it’s a waste of
their time because they’re not interested…’ [Male,
47 yrs, maintained on strong opioids, F1; 365–392]
Long term prescribing often continued because of a
perceived lack of alternative options, with neither party
feeling in control nor achieving satisfactory outcomes.
Continuity of care. Third, GPs were aware of the needs
to get to grips with the key issues in patient narratives
and to explore beliefs or behaviours which influenced
their experience of pain. Some responded by trying to
establish continuity through investing more time in pa-
tients with chronic pain.
‘I think it’s good to take ownership…, because it’s that
collusion of anonymity thing isn’t it? As soon as
someone gets sort of uncomfortable they will shift to a
different prescriber and they will push them along a
certain course and they’ll go, I don’t like that, and
they’ll go to a different one. And I honestly think it’s
like a ship without a rudder and it’s just going round
and round in circles.’ [GP, male, Leeds; 545]
McCrorie et al. BMC Family Practice  (2015) 16:121 Page 4 of 9
Patients also highlighted problems with the lack of
continuity and did not feel their needs could be properly
addressed if their doctors were unfamiliar with their re-
cords. However, taking responsibility and trying to estab-
lish continuity had two potential drawbacks. It had
implications for practice workload and might be per-
ceived as unfair by colleagues because it reduced avail-
ability to see other patients:
‘Would you feel guilty, you know, if you were bringing
back a patient each week? And I think I’d have a bit
of that because I think you don’t want to appear as if
you’re seeing someone over and over again to your
colleagues. I think that… certainly with me that I don’t
want to be seen as that doctor that brings someone
back every week…’ [GP, male, Bradford; 371]
Continuity could also result in stagnation, with losses
of impetus and ideas for change, making it difficult for
GPs or patients to question decisions:
‘She’s [the GP] known me for years and years and she,
she’s really nice and, but sometimes, in a way, knowing
them can be worse, because you don’t tend to question
their judgement, you know, because you don’t want to
offend, if you get what I mean?’ [Female, 37 yrs,
reducing strong opioids, B3:305]
One GP described her discomfort with consultations
dealing with chronic pain and acknowledged that she felt
better equipped to deal with different problems. There-
fore continuity appeared more likely to be productive if
GPs possessed interests and skills in supporting patients
with chronic pain.
Mutuality and trust in the relationship. Finally, mu-
tuality and trust between patients and GPs provided a
platform for negotiating wider aspects of the relation-
ship and considering more holistic approaches to pain
management. However, establishing some level of
trust was difficult when GPs had formed fixed, nega-
tive attitudes towards patients. GPs anticipated that
consultations with certain patients were going to be
problematic; this suggested that the problems resided
as much within the characteristics of the patient as in
the pain itself.
‘I’ve got different responses to different patients I’ve
realised just thinking about them. There’s one or two
that my heart just goes, “oh dear, here we go…”
because I know it’s going to be a tough consultation.’
[GP, female, Leeds; 794]
There could be significant resistance to suggestions of
reducing or stopping opioid treatment:
‘They’ve come in to get more medication and that’s
their agenda. And you’re sitting there with this other
agenda which is, you’re taking too many tablets and
I’ve got to now try and address that with you. That is
like a completely… they’re opposed completely so you
know, they’ve come in with one thing and they know
it’s going to be a battle, they’ve already got their
hackles up.’ [GP, female, Bradford; 1010]
GPs often suspected they were faced with patients be-
ing managed for an incompletely formulated problem,
especially in the presence of known or suspected mental
health problems. Although they recognised the dangers
of continuing or escalating opioid prescribing in such
circumstances, GPs said that prescribing represented a
means to establish trust so that non-pharmacological ap-
proaches could be considered then or at a later point.
‘And then once you’ve got to that point and they’re still
struggling with pain it’s almost having that conversation
where you can then start to say, well maybe it’s not
completely physical…’ [GP, male, Leeds; 343]
Some recognised this as a sub-optimal strategy as
biopsychosocial approaches should ideally have been ad-
dressed at an earlier stage.
Discussion
Patient needs for pain relief, an explanation of their
symptoms and help to improve or maintain their quality
of life were often unmet amongst those we interviewed.
All GPs expressed dissatisfaction with some aspect of
their approach to chronic pain management, be it with
their own consultation skills, the limitations of the
drugs they were prescribing, or the constraints of the
clinical environment. The accounts in this study have
highlighted problematic long-term prescribing, but we
recognise that there will be many clinical encounters
involving the non-problematic management of patients
well controlled on a stable opioid prescription that is
appropriate to their condition. We encountered a now-
familiar story of dissatisfaction on both sides – patients
experiencing repeated consultations that did not meet
their needs, and GPs describing frustration with this
state of affairs and yet with no clear idea of how to
break out of it.
The resulting transaction was an impasse with the fea-
tures of failure of satisfactory management of a long-
term condition. The most striking manifestation of this
failure was that both patients and clinicians recognised
that they did not share a mutually-agreed plan of action,
instead negotiating change through a series of short-
term, often emotionally-charged consultations.
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Three other themes in the clinical encounter confirm
this formulation. First is an awareness of failure to resolve
the tension between patient-centredness and evidence-
based practice [37], generating uncertainty about responsi-
bility for day-to-day symptom management [38]. Second
is ambivalence about the place of relational continuity –
valued in one way to maintain consistency but also seen as
contributing to the nature of the impasse [39]. And finally
there is an awareness of the lack of mutuality in the rela-
tionship – things not being understood, or if understood
then not said: this is an important deficit given the central-
ity of trust to long-term care [40].
Given these circumstances, the continued prescription
of an opioid can seem like the least-worst option for
both parties, but becomes the main – if unintended –
mechanism for preventing resolution. It creates an atmos-
phere of pseudo-mutuality and pseudo-control for both
parties – the patient has got what they requested and the
doctor has acted in role. The medication can reduce
symptoms of distress and anxiety, at least transiently. And
the act of giving and receiving the prescription can look
like active engagement with the main dilemma but is in
fact a form of avoidance, one of a number of strategies
employed as means of not getting uncomfortable uncer-
tainties and differences of opinion into the open [41].
Strengths and limitations
We studied a sample of patients which may be atypical
(more women; mainly prescribed strong opioids) al-
though we did achieve some balance in trajectories. An
alternative of asking GPs to select patients could have
resulted in a different selection bias. There was likely
under-representation of patients from black and minor-
ity ethnic groups. We also studied self-selected GPs who
may have had greater interest in this issue, although our
invitation specifically sought GPs with a range of interests
and only a minority in our sample self-declared interests
in pain. We studied GPs and patients in one geographical
area within the UK National Health Service; however,
similar concerns about prescribing decisions and actions
are emerging elsewhere in other healthcare systems [42].
Our understanding of prescribing trajectories was
based upon subjective accounts of diagnoses and opioid
prescription strength and duration, with discrepancies
between prescription records and what patients re-
ported taking, although this is common for many pre-
scribed medications.
Comparisons with existing literature
Our patient accounts are broadly consistent with those
in a recent meta-ethnography of qualitative studies, par-
ticularly in the ‘adversarial struggle’ patients faced in
constructing explanations for their symptoms and nego-
tiating the healthcare system [30]. Similarly, GPs would
recognise such experiences and have further concerns
around adverse effects, addiction, misuse and probity of
prescribing [21, 43]. Variations in reported practice have
been linked to training in pain management and experi-
ence, including adverse events [31].
Esquibel and Borkan also compared the experiences of
primary care physicians and patients in one US Family
Care Center, separately interviewing each in 21 dyads
[44]. There were many similarities to our findings, such
as challenges in legitimising non-objective pain and
physician feelings of inadequacy as care providers in
treating pain. However, the problems we uncovered with
the lack of management plans and discontinuity were
less apparent, probably because all patients held con-
tracts for opioid treatment of chronic pain and the phy-
sicians knew and nominated each patient interviewed.
Implications for research and practice
Our findings suggest that GPs would be receptive to
guidance on and support with the management of
chronic, non-cancer pain and opioid prescribing. The
content of educational interventions should draw upon
existing good practice guidance [45], and preventive
strategies suggested by our study. These include: early
recognition of at-risk patients who might benefit from
more anticipatory and structured management; checking
patient expectations of opioid therapy and advising on
their limited benefit in chronic pain [46]; and reconsi-
dering strategies of prescribing opioids to establish false
therapeutic relationships.
For those already prescribed opioids, our findings indicate
the need for a systematic approach to each patient that is
not negotiated ‘on the hoof ’ during individual consulta-
tions. A first step in primary care is practice-level reviewing
of prescribing and potential non-pharmacological ap-
proaches to chronic pain management; a plan can then be
formulated that is not over-influenced by the short-term
consultation-by-consultation approach. Consistency in de-
livering this plan requires clear communication, including
agreement of a shared aim within the general practice team
and informational continuity for individual patients. At the
same time, it cannot be assumed that relational continuity
will work in the patient’s best interests, given the risks of
perpetuation of ineffective clinical strategies [47]. Therefore,
practices should consider matching patients with more
problematic issues to GPs with greater skills in pain man-
agement. Subsequent consultations require open and expli-
cit discussions of the element of management plans that is
doctor-driven, including the possibility of non-negotiated
reduction or stopping of opioids, to establish the boundar-
ies of clinical responsibility for prescribing and reduce some
of the mistrust due to lack of openness about plans.
General practice strategies to prevent or manage
problematic opioid prescribing also need support from
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commissioned specialist services which should include
non-drug interventions. There are transferable ele-
ments of collaborative care approaches, effective for
other long term conditions, which enable active com-
munication between GPs and specialists to monitor
and plan patient care [48]. However, there is a need for
rigorously developed and evaluated interventions to
change GPs’ chronic pain management and prescribing
behaviours.
Conclusions
Problematic prescribing occurs when patients experience
repeated consultations that do not meet their needs and
GPs feel unable to negotiate alternative approaches to
treatment. Therapeutic short-termism is perpetuated by
inconsistent clinical encounters and the absence of
mutually-agreed formulations of underlying problems
and plans of action. Apart from commissioning im-
proved access to appropriate specialist services, general
practices should also consider how they manage prob-
lematic opioid prescribing and be prepared to set bound-
aries with patients.
Appendix 1: Patient interview topic guide
Introduction to the interview
Statement about the study aims: purpose is to help us
to understand how, over time, your experiences of being
prescribed painkillers have changed. We are interested
to know how you came to be on painkillers in the first
place and what has happened since then; What I know
about you already (from the opt-in form and why you
have been selected to take part); format; length; breaks;
section of the information leaflet that talks about what
will happen if anything discussed is deemed as a risk.
1. The illness/prescribing career
 List all medications, doses and conditions
 Could you put me in the picture, in a few
sentences, telling me about when your pain began?
Prompts: earliest memory of being in pain; when be-
came aware of it; how often was it happening and for
how long?
 Could you talk me through, from the beginning,
what medication you have been prescribed to help
you with the pain that you get?
Prompts: At the beginning (what happened and why);
how prescription has changed and what led up to these
changes (key events/triggers); who has been involved in
decisions about these changes, why; how feel about your
prescription ‘path; why did you get to where you are (rather
than how)
2. Consultation dynamics
 Can you tell me how you feel about the way in
which your GP/general practice has managed
your pain?
Prompts: how arrived at diagnosis (i.e. investigations),
how do you feel about this (diagnosis and route taken);
who has been involved in managing your pain (e.g. which
health professionals, when in the prescribing career); how
involved do you feel in decisions that influence how your
pain is managed; how do you feel about taking pain-
killers; have there been any attempts to change (decrease,
stop or increase) your painkillers, who by and why,
how do you feel about this; who makes decisions about
changes; more about emotional response to changes (recent
step-ups/downs alterations in dosage) e.g. disapproval in
consultation, responsibility and attribution;
3. Hopes/expectations of prescription
 Can you tell me what impact your painkiller
prescription has on your daily life?
Prompts: How do tablets help you to do the things that
you want to do; what you do, what you can do and what
you would like to do (quality of life/employment/social);
do they affect your mood, in what way, how feel about
this; other physical effects and/or unwanted effects, how
feel about this; how important is your medication regime
in your daily life, why, what would happen if you did not
take them; to what extent do painkillers give you relief from
pain, is this acceptable to you, will this change in the future,
why, in what way, how do you feel about this; how do you
feel about any unresolved pain, will this be different in the
future, in what way, why, how do you feel about this
 Can you tell me what else you have tried to help
manage your pain, besides painkillers?
Prompts: what, why, when in prescribing career, im-
pact, how feel about this; importance of [aids] in relation
to medication and why; what else will you do to manage
your pain in future, why, how do you feel about this
Ending the interview
Checks; prompts; what next
Appendix 2: Patient scenarios for use in focus
groups
Mr W: Current analgesia reported by patient: Fentanyl
transdermal patch (100mcg) change every 2–3 days; tram-
adol 50 mg approx. 15 per day (750 mg daily – prescribed
400 mg); paracetamol prn
Mr W is a 40 year old married man with 3 teenage
children. He currently works full-time in a semi-
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professional job. His low back pain started around
15 years ago. A scan led to a diagnosis of degenerative
discs. A recent second scan shows worsening degener-
ation. He has no other current health problems except
for low mood within the last 2 years.
He has been on numerous strengths and doses of
painkillers since diagnosis (he does not get on well with
anti-inflammatories). He has been prescribed strong opi-
oids (Fentanyl patch) for the past 6 years, increased
gradually over the past year. He has gradually increased
the dose of tramadol himself, especially as he is ‘not get-
ting the same relief that he used to get from his patch’.
His wife is set against any further increases in opioids
and says that his GP is letting her husband ‘self-pre-
scribe’. Mr W complains that the increase in pain is lim-
iting his ability to work, which is ‘what he lives for.’
Mrs R: Current analgesia reported by patient: co-
codamol 30/500 mg x 2 qds; naproxen 250 mg tds; para-
cetamol prn
Mrs R is a 72 year widow who lives with her daughter
and son-in-law. She has a long-standing history of
osteoarthiritis. She had both hips replaced around 5 years
ago. She suffered an MI last year, after which she moved
in with her daughter. She has recently complained of an
increase in the amount of pain she gets from her shoul-
der and knee joints. She feels that her GP has not lis-
tened to her when she asked for help with this in the
past. She was recently referred to and completed physio-
therapy classes. She says that these were ‘a waste of
time.’ It was a massive effort for her to get there and the
classes were often postponed at the last minute due to
staff shortages. Around the same time, she was pre-
scribed a low dose of tramadol but she says she has
stopped taking it as it makes her ‘feel weird.’
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